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Airborneopportunisticfungi,includingAspergillusandotherlesscommonsaprophyticmolds,haverecentlyemergedasimportant
causes of mortality in immunocompromised individuals. Understanding the molecular mechanisms of host-fungal interplay
in robust experimental pathosystems is becoming a research priority for development of novel therapeutics to combat these
devastating infections. Over the past decade, invertebrate hosts with evolutionarily conserved innate immune signaling pathways
a n dp o w e r f u lg e n e t i c s ,s u c ha sDrosophila melanogaster, have been employed as a means to overcome logistic restrains associated
with the use mammalian models of fungal infections. Recent studies in Drosophila models of ﬁlamentous fungi demonstrated that
severalgenesimplicatedinfungalvirulenceinmammalsalsoplayasimilarlyimportantpathogenicroleinfruitﬂies,andimportant
host-related aspects in fungal pathogenesis are evolutionarily conserved. In view of recent advances in Drosophila genetics, fruit
ﬂies will become an invaluable surrogate model to study immunopathogenesis of fungal diseases.
1.Introduction
In recent years, opportunistic fungi have emerged as leading
causes of morbidity and mortality in immunocompromised
individuals [1–3]. Aspergillus is by far the most common
of these molds, and mortality rates for invasive aspergillosis
exceed 90% in hematopoietic stem cell transplant recipients
[4, 5]. Even more concerning, however, is that infections
caused by other diﬃcult-to-treat opportunistic molds, such
as Mucorales species, are increasingly being observed in
several cancer centers [6–8]. The increase in the frequency
and spectrum of invasive fungal infections in immuno-
compromised patients underscores the need for expanding
our knowledge of the pathogenesis of opportunistic fungal
infections and developing novel therapeutic approaches.
The versatility and complexity of virulence mechanisms
and predisposing host conditions that lead to development
of invasive mold infections [9, 10] necessitate understanding
the nature of host-fungal interactions at the cellular and
molecular levels in order to identify host immune pathways
and pathogen determinants involved in disease progression
[11, 12]. Pioneering studies over the past decade demon-
strated that a variety of opportunistic fungi can invade
and cause fatal infection in a variety of simple invertebrate
hosts, such as the fruit ﬂy Drosophila melanogaster,a n d
the roundworm Caenorhabditis elegans [13–20]. Also, it has
become evident from these studies that important aspects of
innate immunity have been evolutionarily conserved across
phylogeny. Thus, because of their simplicity, well character-
ized innate immune signaling pathways, and because both
the host and pathogen are amenable to genetic analysis and
high-throughput screening in each of these pathosystems,
the use of invertebrate models has accelerated studies of
microbial virulence and host immunity [21–24]. In addition,2 International Journal of Microbiology
because of their low cost, small size, and short generation
time, invertebrate hosts have been used in mass screening
assays for selection of antimicrobial compounds with novel
mechanisms of action. In this review, we outline recent
advances in the study of medically important ﬁlamentous
fungi in Drosophila model and discuss future implications
and challenges in the use of this elegant pathosystem.
2.AntifungalInnateImmunePathwaysin
Drosophila melanogaster
2.1. Humoral Antifungal Immune Responses. Although lack-
ing adaptive immunity, invertebrates are capable of hav-
ing eﬃcient innate immune responses against an array
of pathogens in their natural environments. Two major
pathways orchestrate innate immune responses in D.
melanogaster, the immune deﬁciency (imd) pathway that
confers protection against gram-negative bacteria, and the
Toll pathway that is critical for immunity against gram-
positive bacteria and fungi [25]. Detection of invading
microorganisms by host receptors of the peptidoglycan
recognition protein (PGRP) or gram-negative binding pro-
tein (GNBP) families triggers the activation of signal
transduction pathways in the fat body (liver analogue) via
the Toll receptor leading to a systemic humoral response
characterized primarily by massive synthesis and release of
potent antimicrobial peptides. Despite the broad spectrum
of antimicrobial peptides, some speciﬁcity exists upon
their induction following infection by various microbial
pathogens. For example, in D. melanogaster,f u n gia n dgra m -
positive bacteria mainly induce the production and release of
drosomycin and metchnikowin via the Toll pathway, whereas
gram-negative microbes induce the production and release
of diptericin, attacin, and cecropin via the imd pathway [25].
The predominant role of the Toll pathway in Drosophila
immunity against Aspergillus w a sﬁ r s td e m o n s t r a t e di na
landmark study by Lemaitre et al. [17], who found that
Toll mutant ﬂies, in contrast to wild-type ﬂies, were highly
susceptible to Aspergillus infection.
In both insects and mammals, the interaction of
immunostimulatory cell wall molecules of invading fungi
with Toll receptor(s) leads to activation of intracellular
phosphorylation cascades, with subsequent translocation of
nuclear factor κB-like transcriptional factors to the nucleus
and induction of antimicrobial peptide-encoding genes [10,
25]. However, in contrast to mammalian Toll receptors,
there is no direct interaction between microbial ligands
and Drosophila Toll r e c e p t o r .I n s t e a d ,a c t i v a t i o no ft h eToll
signaling cascade is mediated by GNBP-3, a soluble pattern
recognition receptor that senses long-chain fungal b-(1–3)-
glucans and triggers a serine protease cascade leading to
the processing of a small cytokine-like molecule, Sp¨ atzle,
which comprises the functional ligand of the Toll receptor
[25]. Importantly, GNBP3 mutant ﬂies are highly susceptible
to opportunistic fungi, including Candida and Aspergillus
while retain functional Toll pathway activity, implying Toll-
independent immune-related functions of this receptor.
Indeed, GNBP3 has been implicated to play a role in
pathogen agglutination, and activation of the melaniza-
tion reaction at the early stages of fungal invasion [26].
Importantly, parallel to GNBP3, a second detection system
senses the activity of proteolytic virulence factors that are
released in the ﬂy hemolymph during invasive fungal growth
and redundantly activates Toll pathway via the protease
Persephone [27].
2.2. Cellular Antifungal Immune Responses. When compared
to humoral immune responses, D. melanogaster cellular
immuneresponsesarelesswellcharacterized.Notably,recent
studies in insects challenge the importance of humoral
immunityinpathogenclearance,demonstratingthatthevast
majority of bacteria (99.5%) are rapidly eliminated from
the haemolymph well before the induction of antimicrobial
peptides [28]. Hence, cellular immune responses seem to
play instrumental roles in early recognition and elimination
of microbial pathogens. The key transcription factor down-
stream of the Toll pathway, the nuclear factor-κB homologue
Dif, is required for regulation of both humoral and cellular
immunity in ﬂies [25]. Phagocytosis is a hallmark of the cel-
lular immune response and exhibits considerable similarity
across phylogeny. Hence, opsonization and recognition by
speciﬁcreceptorsmediatetheinitial stagesofphagocytosisin
bothinvertebratesandmammals.Forexample,inDrosophila
peptidoglycan, recognition proteins (PGRPs) such as PGRP-
LC and Croquemort (a human CD36 homologue) partici-
pate in the recognition and phagocytosis of gram-negative
bacteria [29, 30], whereas the transmembrane scavenger
receptor eater has been shown to recognize bacteria and
fungi (Candida silvata) and play a Toll-independent role
in antifungal immunity [23, 31]. Of interest, thioester-
containing proteins with a complement-like activity against
invading pathogens have been identiﬁed in many insects,
including fruit ﬂies [25, 32]. A high-throughput screen
in Drosophila melanogaster S2 RNAi library identiﬁed a
novel protein, macroglobulin complement related (Mcr),
that exerts opsonizing activity speciﬁcally against Candida
albicans[33].Inaddition,S2Drosophilacells eﬃcientlyelim-
inate C. albicans yeast cells and induce signiﬁcant damage to
the hyphae of ﬁlamentous fungi, including Aspergillus and
the Mucorales, in a way that resembles the antifungal eﬀector
function of human phagocytes [23, 34].
The molecular mechanisms of intracellular elimination
of pathogens by Drosophila phagocytic cells are less well
characterized. Thus, insect phagocytic cells are also capable
of generating an oxidative burst of oxygen radical interme-
diates, whereas induction of nitric oxide synthase has been
shown to protect against bacterial infection in Drosophila
larvae [35]. Furthermore, numerous antimicrobial pep-
tides contained within human neutrophil granules, such
as lysozyme, lipases, metalloproteases (like the mammalian
gelatinases or collagenases), and nucleases, are similarly
produced by the phagocytic hemocytes of most insects in
responsetoinfection[11,25].Althoughlittleisknownabout
the molecular mechanisms of intracellular elimination of
pathogens in fruit ﬂies, recent studies demonstrate that the
evolutionarily conserved autophagy pathway is importantInternational Journal of Microbiology 3
for immune surveillance and clearance of intracellular
pathogens that escape into the cytoplasm, including Cryp-
tococcus [36]. On the other hand, unique cellular responses
against larger invading pathogens (e.g., parasites), such as
encapsulation and melanization mediated by specialized
immune eﬀector cells, are seen in Drosophila and other
insects [11, 25].
2.3. Epithelial Immune Responses. In D. melanogaster,
antimicrobial peptide-encoding genes are constitutively
expressed in epithelia that are in direct contact with the
external environment. However, in contrast with the sys-
temic immune responses mediated by the fat body, where
theToll pathwaymodulatesimmuneresponsesagainstgram-
positive bacteria and fungi, epithelial immune responses in
D. melanogaster appear to be partially controlled by the Imd
pathway [25]. Furthermore, recent evidence indicates that
genes involved in oxidative stress and/or detoxiﬁcation of
reactive oxygen species are critical for epithelial defense [37].
In addition, recent studies demonstrated a major role for
the Janus kinase- (JAK-) signal transducer and activator of
transcription (STAT) signaling pathway in epithelial host
defenseviaregulationofstemcellproliferationandepithelial
cell homeostasis [38].
A recent study in a gastrointestinal infection (GI)
model of candidiasis in Drosophila larvae demonstrated an
important role of normal gut ﬂora in epithelial immunity by
preventing colonization and invasive infection by Candida,
which resembles the increasingly appreciated regulatory
role of human epithelial microbiota in shaping epithelial
immune responses [39]. Of interest, activation of JNK
signaling during Candida infection accounted for extensive
epithelial cell death in the gut and mortality of Drosophila
larvae. In parallel, Candida infection triggered a systemic
protective immune response that was mediated by NO
release from larvae hemocytes and the parallel activation
of the Toll pathway by pathogen-secreted aspartyl pro-
teinases.
2.4. Toll-Independent Innate Immune Pathways in Drosophila.
The complexity of the immune defenses in insects is much
higher than initially perceived, and cross-talk between the
Imd and Toll pathways takes place in response to both gram-
negative and gram-positive microbes [25]. Furthermore,
besides the Toll and Imd signaling cascades, other pathways
associated with developmental or stress resistance processes
are induced in response to infections in both invertebrates
and mammals. For example, a pioneer study in Drosophila
demonstrated that antimicrobial peptide activation can be
achieved independently of classic immunoregulatory path-
ways by the transcription factor FOXO, a key regulator
of stress resistance, metabolism, and aging [40]. In unin-
fected animals, antimicrobial peptide genes are activated
in response to nuclear FOXO activity when induced by
starvation or by using insulin-signaling mutants, revealing
a new mechanism of cross-regulation of metabolism and
innate immunity that has proven to be functional in humans
as well [40]. Furthermore, investigators showed that the
activation of the evolutionarily conserved p38 MAPK path-
way is important for resistance to infection by bacteria and
fungi; of interest, in contrast to the mammalian homologue,
activation of p38 MAPK occurs independently of the Toll
signaling [41].
3. Modeling MicrobialInfection in
Drosophila melanogaster
In D. melanogaster, the pathogen of interest is typically
injected into the dorsal thorax via either needle pricking
or microinjection [11]. In regard to fungal pathogens, the
injection assay is technically a more standardized and repro-
ducible method of infection and allows for a more precise
estimation of fungal inoculums. Nonetheless, parenteral
inoculation by passes the physiologic route of entry of the
pathogen of interest and results in a more overwhelming
infection that may not be suitable for pathogenesis studies.
Thus, other more physiologic methods of infection are also
used. For example, the alb1 Aspergillus fumigatus mutant,
whichishypovirulentinmice,exhibitedattenuatedvirulence
in Toll-deﬁcient ﬂies only when introduced by feeding or
rolling [20]. These infection methods are typically achieved
by feeding insects in a lawn of yeast or molds or rolling
insects over a fresh carpet of fungal spores. However,
standardization of the infecting inocula is diﬃcult with
natural infection methods such as ingestion. Furthermore,
infection with molds other than Aspergillus by feeding and
rolling is diﬃcult to perform because of the distinct pattern
of growth of fungal colonies.
Female ﬂies are typically used in infection experiments
because of their larger size and relative resistance to injection
injury when compared with male ﬂies. Because wild-type
Drosophilaisresistanttomostpathogenicfungiandbacteria,
mutants deﬁcient in various components of the Toll cascade
are frequently employed to model infections. In most cases,
crossing diﬀerent loss-of-function alleles is required to
generate homozygous Toll-mutant ﬂies [11]. Nonetheless,
the need for crossing of ﬂy strains is a limitation for
high throughput screening assays. Of note, microinjection
introduces signiﬁcantly higher inoculums within Drosophila
hemolymph than needle pricking that allowed for establish-
ment of invasive Candida infection in wild-type Drosophila
melanogaster ﬂies [42].
A major advantage of Drosophila in comparison to all
other model host organisms is its genetic tractability, well-
characterized immune system, and remarkable degree in
conservation of biochemical pathways that control fun-
damental physiologic processes such as cell proliferation,
diﬀerentiation, and tissue homeostasis. Furthermore, the
innate susceptibility of Drosophila Toll mutant strains
to fungal infections obviates the need to use immuno-
suppressive agents, thus eliminating the host variability
inherent in the use of immunosuppressive regimens. In
particular, Drosophila strains are amenable to both forward
and reverse genetics, and large collections of Drosophila
mutants and transgenic cell lines are commercially available
(http://ﬂybase.net/). Also, the Drosophila genome sequence4 International Journal of Microbiology
was one of the ﬁrst to be completed and is proba-
bly one of the most fully annotated eukaryotic genomes
found in a database (http://ﬂybase.net/annot/). As a result,
double-stranded RNA has been synthesized for each of the
Drosophila genes (http://www.ﬂyrnai.org/) and recently lines
expressing RNAi have become available, which allow for
conditional inactivation of every single gene at a whole
animal or tissue level (http://www.vdrc.at/).
4. Virulence Studies of Filamentous Fungi in
Drosophila melanogaster
4.1. Aspergillus. Since ﬁlamentous fungi have been in exis-
tenceforabout1billionyears,theﬂyimmunesystemevolved
in the face of continued exposure to airborne conidia.
Thus, Drosophila immune system has developed highly
sophisticated and eﬃcient strategies to combat infection
caused by Aspergillus and other ﬁlamentous fungi. In fact,
only a few entomopathogenic fungi are able to infect fruit
ﬂies in nature, via penetration of ﬂy exoskeleton. Even when
fungal pathogens are experimentally introduced directly
into the ﬂy hemolymph, wild-type ﬂies are still capable
of eﬀectively eliminating infection. Lemaitre and colleagues
were the ﬁrst to demonstrate that Aspergillus fumigatus was
able to infect and kill ﬂies carrying mutations in various
aspects of the Toll pathway [17]. Toll-deﬁcient ﬂies have been
sinceimplemented asamodeltostudyimmunopathogenesis
of infections caused by Aspergillus and other medically
important ﬁlamentous fungi. Several virulence attributes of
Aspergillus pathogenicityinmammalshavebeentestedinthe
ﬂy model [20, 43]. With the exception of virulent factors
that are important for microbial survival at mammalian
temperature [44], most other virulence attributes that are
important for mammalian pathogenicity of Aspergillus were
equally important for successful infection in Toll-deﬁcient
fruit ﬂies. In particular, Aspergillus mutants that are defective
in siderophore biosynthesis (DeltasidA, DeltasidD), PABA
metabolism (H515), starvation stress response, secondary
metaboliteproduction(DgliP),ormelaninbiosynthesiswere
attenuated in both Drosophila and mouse models of invasive
aspergillosis [20, 43]. Notably, fungal cell wall melanin was
dispensableforAspergillus virulencewhenfungalsporeswere
injectedintotheﬂyhemolymphbutwasimportantforestab-
lishment of invasive infection though Drosophila epithelia
[20]. Hence, the tempo and site of infection as well as
diﬀerences in local host defense mechanisms may inﬂuence
expression of virulence factors of fungi in the ﬂy model.
Evermore, similar to recent ﬁndings with the Δ CgrA mutant
[44], putative virulent factors of A. fumigatus with a role in
thermotolerance may not be encountered in Drosophila or
other invertebrate models because infection in these mini-
hoststakesplaceattemperaturesmuchlower(25◦C)thanthe
mammalian physiologic temperature (37◦C). Despite these
limitations, accumulating experimental evidence suggests
that Drosophila is a relevance model to study Aspergillus
virulence.
The interstrain and interspecies variations in virulence
for a collection of Aspergillus fumigatus and Aspergillus
terreus clinical isolates were recently studied in Toll-deﬁcient
fruit ﬂies [45]. Although there was no signiﬁcant diﬀerence
inthesurvivalofﬂiesinfectedwithA.fumigatusversusA.ter-
reus or ﬂies infected with colonizing versus invasive isolates
of either species, two dominant A. fumigatus clades identi-
ﬁed by rep-PCR were associated with signiﬁcantly diﬀerent
survival rates in Toll-deﬁcient ﬂies. Therefore, the ﬂy model
of aspergillosis could detect subtle changes in virulence and
uncover distinct A. fumigatus clades that diﬀer in their
pathogenicity. Of interest, a similar pathogenicity study of
Candida albicans clinical isolates that were previously ranked
for virulence in mice was recently performed in wild-type
Drosophila ﬂies infected by microinjection [42]. Of interest,
there was a signiﬁcant correlation in virulence of C. albicans
strains between the ﬂy and the mouse model of disseminated
candidiasis. Nonetheless, diﬀerences in virulence were not
evident using immune-deﬁcient spatzle−/− ﬂies, suggesting
that Toll signalling might actually be required to predictably
diﬀerentiate virulence.
The recent completion of the sequencing of the A. fumi-
gatus genome and the development of molecular toolsets
to study the biology of A. fumigatus is expected to lead to
the generation of multiple Aspergillus mutants and creates
a need for high-throughput strategies capable of assessing
the contribution of individual genes to Aspergillus virulence
[46]. Validation of Drosophila as a suitable model for large-
scale virulence studies was provided by a recent screen of 34
Candida albicans mutants defective in putative transcription
factor genes. This study identiﬁed a novel transcriptional
regulator of cell wall integrity, CAS5, which proved to
be important for virulence in both Drosophila and the
mouse model of invasive candidiasis; a parallel screen in C.
elegans subsequently conﬁrmed the role of CAS5 in Candida
virulence [47].
4.2. Mucorales (Formerly Zygomycetes). Mucorales species
have recently emerged as an important cause of serious
angioinvasive infections in immunocompromised individ-
uals [6–8]. Rhizopus species accounts for majority of cases
of mucormycosis in humans [7]. Few animal models of
mucormycosis exist, and the immunopathogenesis of this
infection is largely unknown. However, sequencing of
Rhizopus oryzae genome has been completed and genetic
tools are available (http://www.broad.mit.edu/annotation/
fungi/rhizopus oryzae/). In immunocompetent individuals,
blood and tissue phagocytes eﬃciently eliminate Mucorales
spores and hyphae by oxidative and nonoxidative killing
mechanisms. Quantitative (i.e., neutropenia) or qualitative
(i.e., associated with glucocorticoids, hyperglycemia, and/or
acidosis) defects in phagocytic cell activity permit unre-
stricted growth of the hyphal form and invasive infection.
Iron metabolism has a central role in pathogenesis of
mucormycosis [6–8]. Thus, patients with iron overload
states, including individuals undergoing chelation therapy
with deferoxamine, are uniquely predisposed to mucormy-
cosis. Of interest, deferoxamine acts as a siderophore for
Mucorales species and promotes in vitro fungal growth.
Similarly, the increased availability of serum iron in patientsInternational Journal of Microbiology 5
with diabetic acidosis partially accounts for their unique
susceptibilitytomucormycosis.Asoppositetodeferoxamine,
otherironchelatorssuchasdeferasiroxlackxenosiderophore
activity for Rhizopus induce an iron-starvation eﬀect to the
fungus and have shown to be protective in animal models of
mucormycosis [6–8].
Although Mucorales have not be reported to be ento-
mopathogenic, we recently found that as opposite to other
medically important ﬁlamentous fungi, injection of diﬀerent
Mucorales species in wild-type D. melanogaster results in
a hyperacute infection, with disseminated fungal prolif-
eration and high mortality rates [23]. Several aspects of
immunopathogenesis of mucormycosis in humans were
modeled in Drosophila, including increased host suscepti-
bility following administration of corticosteroids, and the
iron chelator deferoxamine. Of interest, the use of another
iron chelator, deferasirox, which induces iron starvation
to Mucorales spp and protects mice and possibly humans
from infection, also signiﬁcantly protected Drosophila from
mucormycosis. In addition, Cunninghamella berthollethiae,
which appears to be the most virulent Mucorales species
in humans, exhibited increased virulence in comparison to
other Mucorales species in the ﬂy model [23].
The ﬂy model of mucormycosis has been established in
wild-type Drosophila, which obviates the need for crossings
and allows for simple and rapid assessment of research ques-
tions in Mucorales pathogenicity. Thus, ﬂies were recently
implemented to evaluate the role of endosymbiotic toxin-
producing bacteria in the virulence of Rhizopus species.
Although a signiﬁcant number of clinical Rhizopus isolates
were found to harbor rhizoxin-producing bacteria, there was
no diﬀerence in fungal virulence following antibiotic medi-
ated eradication of the endosimbionts in both Drosophila
and mice [48]. In addition, the association of increased
voriconazole use with the emergence of Mucorales infection
in immunocompromised patients was recently tested in the
ﬂy model. Surprisingly, preexposure of Mucorales to this
newer triazole dramatically increased susceptibility of fruit
ﬂies to mucormycosis in Toll-independent fashion, which
was also observed in the mouse model [49]. Collectively,
these studies demonstrate that Mucorales species have devel-
oped common virulence strategies to invade evolutionarily
disparate organisms such as Drosophila and humans.
Of interest, virulence of Cunninghamella in the ﬂy model
is signiﬁcantly aﬀected by the composition of fungal culture
media, possibly reﬂecting diﬀerences in acquisition of iron
or other nutritional factors [50]. In addition, because innate
immunity in Drosophila is under circadian regulation, the
timing of infection has signiﬁcant impact in host defense
against various pathogens, including ﬁlamentous fungi. In
fact, genes involved in circadian rhythm regulation were
signiﬁcantly induced following infection with Mucorales
species in Drosophila [23]. Furthermore, starvation of ﬂies
prior to infection confers protection against bacterial infec-
tion via release of NO [51], and possibly via regulating other
immune-related pathways, such as FOXO signaling [40]a n d
the autophagy response. Therefore,allthese parameters need
to be considered in virulence testing of Mucorales and other
ﬁlamentous fungi in Drosophila.
Gene expression proﬁling in human monocytes and in
immunocompromised mice infected with Rhizopus versus
Aspergillus demonstratesadiﬀerentialinductionofimmune-
related genes during mucormycosis [52], whichlikely reﬂects
unique virulence traits of Mucorales species. Similarly, tran-
scriptional proﬁling at early time points of infection in wild-
type fruit ﬂies infected with Rhizopus (pathogenic) versus
Aspergillus (nonpathogenic) indicated distinct sets of genes
that were selectively regulated in response to mucormycosis
[23]. These genes could represent molecular targets for
drug development aiming at modulating host immune
response during infection. Of interest, a similar transcrip-
tome proﬁling in Drosophila infected with two strains of
Pseudomonas with diﬀerent pathogenic properties revealed
common groups of genes with those identiﬁed during Rhi-
zopus infection of ﬂies [53] .N o t a b l y ,ag r o u po fg e n e sd o w n
regulated following infection with the pathogenic strain
in both studies included a skeletal muscle gene regulatory
network under the control of cJun-N-terminal Kinase (JNK)
pathway. Notably, activation of this pathway promoted local
resistance to P. aeruginosa in ﬂies and mice [54].
4.3. Other Emerging Filamentous Fungi. Fusarium and Sce-
dosporium species are ubiquitous, saprophytic molds that
are notoriously resistant to conventional antifungal agents
[2]. These fungi have been increasingly reported causes of
invasive, frequently fatal infections in immunosuppressed
hosts. Occasionally, these opportunistic pathogens can cause
diﬃcult-to-treat localized infections in immunocompetent
individuals with certain predisposing conditions, including
onychomycosis, fungal keratitis, skin and soft tissue infec-
tion, and rarely brain abscesses [2]. Furthermore, as opposite
to other ﬁlamentous fungi, Fusarium species have a unique
predisposition for development of fungemia and dissemi-
nated necrotic skin lesions in severely immunocompromised
patients [2]. These features suggest the existence of unchar-
acterized, unique virulence factors of these organisms.
Drosophila melanogaster wild-type ﬂies were recently found
to be resistant to infection by diﬀerent clinical isolates of
Scedosporium,whereasToll-deﬁcientﬂieswerehighlysuscep-
tible to these fungi [24]. Of interest, Fusarium species caused
lethal infection in wild-type ﬂies although in a less acute
mode of infection than in Toll deﬁcient ﬂies, an observation
consistent with the ability of these fungi to infect a broad
range of phylogenetically disparate hosts, ranging from
plants to mammals. Although the lack of genetic tools cur-
rently precludes comprehensive analysis of virulence factors
in these fungi, comparative analysis of host defense mech-
anisms during infection with these and other ﬁlamentous
fungi in the Drosophila model could provide valuable infor-
mation on the pathogenesis of these emerging infections.
5. AntifungalDrugEfﬁcacy Studiesin
Drosophila Models of Filamentous Fungi
Drosophila has proven to be a reliable model for testing
orally absorbed compounds with antifungal activity. In
particular, voriconazole conferred signiﬁcant protection in6 International Journal of Microbiology
Toll-mutant ﬂies infected with A. fumigatus [20]. Further-
more, the combination of voriconazole and terbinaﬁne,
two drugs that block sequential steps in the ergosterol
pathway and show synergy in vitro against Aspergillus,w a s
synergistic in the Drosophila model of aspergillosis [20].
Similarly, voriconazole preexposure was protective in ﬂies
infected with Fusarium moniliforme and S. apiospermum,
but not in ﬂies infected with S. proliﬁcans, a ﬁnding that
is consistent with in vitro susceptibilities of these species
and in vivo studies in mice [24]. Besides conventional
antifungal agents, administration of deferasirox, an iron
chelator that induces iron starvation and exerts selective
antifungal activity against Mucorales, signiﬁcantly increased
survival of ﬂies in Drosophila model of mucormycosis [23].
Nonetheless, there are important limitations in the
use of Drosophila and other invertebrate models in drug
eﬃcacy studies. Thus, precise estimation of the dose of a
pharmacologic compound that is orally administered in ﬂies
is challenging. A more accurate way of drug delivery can be
achieved by microinjection; however, this method is time
consuming and requires technical training and specialized
equipment in fruit ﬂies. In addition, measurement of drug
levels for pharmacokinetic analysis in Drosophila requires
HPLC or bioassay methods that are more cumbersome,
imprecise, and technically demanding in this model than
in mammals [11]. For all these reasons, pharmacodynamic
studies, which typically require multiple dosing of antifungal
agentsforlongperiodsoftime,arenotfeasibleinDrosophila.
Finally, the metabolism and elimination pathways of drugs
and the potential for drug-drug interactions are largely
unknown in Drosophila for most existing compounds.
Despite their limitations, Drosophila and other inverte-
brates are attractive models for mass-screening candidate
antifungal compounds that will require subsequent valida-
tion in mammalian systems [55]. Such approaches have
been used successfully in Drosophila to select life-extending
compounds [56] and recently in C. elegans to identify
compounds with novel mechanism of antifungal activity
against Candida [57]. In the C. elegans study, thousands
of synthetic and natural molecules were screened in a 96-
well plate liquid culture system and several compounds
that exhibited in vivo activity without signiﬁcant in vitro
eﬀect were selected, proving the beneﬁts of this strategy.
Notably, two of the 15 selected compounds identiﬁed in
this screening exhibited potent antifungal activity in the
mouse model of invasive candidiasis [57]. Overall, the
simplicity, low cost, small size, and short generation time
of invertebrate hosts make them ideal for high-throughput
screening. As a proof of principle, many pharmaceutical and
biotechnology companies are increasingly using minihost
models for drug discovery. For example, Exelixis, Inc. (South
San Francisco, CA) has created an extensive collection of
Drosophila gene disruption strains for use in drug-target
identiﬁcation. Similarly, larger pharmaceutical companies
suchasNovartis(Basel,Switzerland)havecreatedDrosophila
functional genomics departments dedicated to the study
of disease-related pathways and discovery of novel drug
targets. Nonetheless, D. melanogaster models of infectious
diseases are less amenable to automated mass screening for
antimicrobial agents than are C. elegans models because
of technical limitations associated with the size of the
animals, methods of infection, frequent need for ﬂy crosses
to generate the desired mutants, and inability of adult ﬂies to
propagate in liquid culture systems.
6. Implementing RNAi Screensto
Identify Host and Pathogen Determinants of
Immunopathogenesis of FungalDiseases
Over the past few years, Drosophila melanogaster S2 cells
a n dR N A it e c h n o l o gyh a v eb e e ns u c c e s s f u l l yi m p l e m e n t e dt o
identify host factors implicated in pathogenesis of infections
caused by intracellular pathogens [29, 30, 58]. There are
many features of the Drosophila cell system that make it an
attractive tool for these studies. Hence, the ﬂy genome is
highly annotated and fundamental innate immune pathways
are evolutionarily conserved in Drosophila S2 macrophage-
like cells. Furthermore, gene silencing is easier to perform
in a high-throughput basis in Drosophila cell lines when
compared to mammalian macrophage cell lines. Finally,
Drosophila S2 cells have a successful track record in identi-
fying novel host factors involved in phagocytosis and killing
of many intracellular microbial pathogens, which have been
subsequently validated in their mammalian cell counterparts
[29, 30, 58]. In regard to fungal pathogens, investigators
recently used an RNAi library of S2 cells to study genes
involved in phagocytosis of C. albicans and identiﬁed novel
genes encoding for proteins that speciﬁcally recognize and
promote phagocytosis of Candida yeast cells [33]. Another
RNAi screen in S2 cells was designed to select host factors
that restrict intracellular survival and proliferation of the
pathogenic fungus, Cryptococcus neoformans [36]. This study
identiﬁed novel host genes implicated in Cryptococcus patho-
genesis and revealed that proteins of the autophagy pathway
areimportantforintracellulareliminationofthefungusboth
in Drosophila S2 cells and mammalian macrophages.
In vitro, high-throughput screening strategies using
phagocyticD. melanogaster celllineshavecertainlimitations.
First, only host factors important for the intracellular life
cycle of a pathogen can be tested. This approach is well
suited for intracellular pathogens but not for extracellular
organisms such as ﬁlamentous fungi. Thus, in contrast
with bacteria, fungi have distinct replication stages (e.g.,
spore to hyphal transition) and relatively slow growth rates,
which make diﬃcult the establishment of reliable high-
throughput phagocytosis and/or killing in vitro assays. In
addition, silencing of important innate immune-related
pathways may be missed in an in vitro screen because it may
result in nonviable phenotypes, which can only be assessed
using tissue-speciﬁc silencing in vivo. Finally, the complexity
and dynamics of in vivo host-pathogen interplay, including
tissue-speciﬁc host immune responses, cannot be reliably
evaluated using an in vitro culture system.
Studies using conditional RNAi in D. melanogaster to
analyze gene function in real time and a tissue-speciﬁc
manner could overcome limitations of in vitro large-scale
screening.Infact,theinvivoRNAilibraryforDrosophilaﬂiesInternational Journal of Microbiology 7
Fungal libraries
High-throughput screens
Drosophila S2 cells
(in vitro RNAi screen)
Drosophila RNAi lines
(in vivo screens)
Target validation Target validation
Mammalian cells Mouse model
Figure 1: Prioritizing use of Drosophila model in selection of novel determinants of fungal pathogenicity in humans.
Table 1: Important research questions on antifungal immunity in Drosophila.
Which host defense mechanisms in Drosophila are important for fungal clearance before the induction of
humoral immune responses?
What is the contribution of cellular immunity in defense against fungi?
How Drosophila immune system discriminates opportunistic from entomopathogenic fungi?
Which fungal molecules other than b-glucans trigger activation of host immune responses in Drosophila?
Are there any fungal virulence factors that exert immunosuppressive eﬀects on Toll signaling or other immune
signaling pathways?
Is there any role of pathogen or self-nucleic acid sensing in Drosophila host defense?
How Drosophila discriminates sensing of self- from non-self-immune activating molecules?
Is there any evidence of the presence of endogenous ligands for Drosophila pattern recognition receptors?
Are there any immune modulating properties of the antimicrobial peptides in Drosophila?
Is there any role for antimicrobial peptide-DNA complex formation in insect immunity against fungi?
Is there any cooperative activity between diﬀerent Drosophila immune receptors?
hasbecamecommerciallyavailable[59],andapilot genome-
wide in vivo screen in D. melanogaster designed to identify
genes involved in epithelial host defense against an intestinal
bacterial pathogen was recently completed [38]. For the ﬁrst
time,thisstudyshowedthattheJAK-STATsignalingpathway
has an important role in host defense against infections with
bacterial pathogens in the gut by regulating epithelial cell
homeostasis.
7. Limitationsof Drosophila Model of
FungalInfections
Drosophila oﬀers unique advantages in dissecting immuno-
pathogenesis of fungal diseases because of its powerful
genetics and highly conserved immune pathways. Nonethe-
less, the ﬂy model also has some obvious limitations. For
example, implementing Toll-deﬁcient ﬂies as model for
virulence testing in a Mycology laboratory requires some
degree of training for proper maintenance and crossing of
Drosophila stocks, and basic equipment for manipulating,
anesthetizing, and infecting the animals. Alternatively, use of
larger in size invertebrates, such as Galleria mellonella,w h i c h
are easier to infect and allow for infection at mammalian
temperatures, could overcome some technical diﬃculties of
the Drosophila model [60]. However, because in Galleria
mellonella genetic tools are not available and innate immune
pathwaysarelesswellcharacterized,thismodelisnotsuitable
for in-depth analysis of host-related factors mediating fungal
pathogenesis.
When compared to conventional animal models, the
considerable diﬀerence in the anatomic structures of inver-
tebrates and mammals raises questions on the pathophysi-
ologic relevance of some D. melanogaster infection models.
This may be particularly true for pathogens with life cycles
adapted to mammalian hosts, or those that express their
virulence mechanisms in a tissue-speciﬁc environment. For
example, establishing a model of Pneumocystis jirovecii in8 International Journal of Microbiology
invertebrate hosts [61] is not feasible. Nonetheless, even in
mammalianhosts,somevirulenceattributesofpathogenicity
may be dispensable to certain pathophysiologic settings or
infection sites. For example, researchers recently showed
that gliotoxin production was required for A. fumigatus
pathogenicityincorticosteroid-immunosuppressedmicebut
not in neutropenic mice [62]. Furthermore, D. melanogaster
lacks important constituents of human immunity, including
a functional adaptive immune response, highly specialized
innateimmunecellsubsets(e.g.,dendriticcells,naturalkiller
cells), and a complex network of cytokines, chemokines, and
other eﬀector molecules that have critical roles in orchestrat-
ing cell communication and regulation of inﬂammation and
tolerance during infection. Overall, despite the considerable
similarities in innate immune mechanisms, invertebrate
models are not directly comparable with mammalian mod-
els. Thus, it is reasonable to speculate that some of the
virulence attributes of Aspergillus and other ﬁlamentous
fungi that aﬀect mammals might not be important in
invertebrateminihostmodels.Therefore, Drosophilamust be
viewed as a complementary, high-throughput genetic model,
which could accelerate identiﬁcation of novel host and
pathogen determinants with a relevant role in development
of fungal diseases in humans (Figure 1).
8.FutureDirectionsinFungal Immunology
Research in Drosophila
The identiﬁcation of the Drosophila melanogaster Toll sig-
naling cascade and the subsequent characterization of mam-
malian Toll-like receptors (TLRs) have fundamentally altered
our understanding of innate immunity. However, much
remains to be learned on evolutionarily conserved antifun-
gal immune defense mechanisms in Drosophila (Table 1).
For example, whether immunostimulatory molecules of
fungi other than b-glucans trigger immune recognition
in Drosophila has not been elucidated. In addition, it
is unknown whether and how Drosophila discriminates
between pathogenic and opportunistic fungi. Similarly, the
contribution of cellular immunity and Toll-independent
mechanisms of antifungal host defense in fruit ﬂies remains
to be explored. Since the identiﬁcation of mammalian TLRs,
it became evident that nucleic acid sensing is an important
aspect in pathogen recognition. Hence, dedicated endosomal
TLRs and cytoplasmic pattern recognition receptors are
specialized in sensing bacterial and viral nucleic acids
and trigger robust inﬂammatory responses. Recent studies
also demonstrate an important role for DNA neutrophil
extracellular trap (NET) formation during bacterial and
fungal infections [63]. In Drosophila, the role of nucleic acid
sensing in immunity is largely unknown. Nonetheless, recent
studies in other insects suggest that DNA NET formation
is important for innate antibacterial immunity [64]. Finally,
in humans, evolutionarily conserved antimicrobial peptides
exertimportantimmunomodulatorypropertiesbesidestheir
direct eﬀector function, by acting on various chemokine and
signaling receptors [65, 66]. Therefore, whether Drosophila
antimicrobial peptides retain a similar role is an important
research direction in understanding the evolution of mam-
malian immune system.
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